References
- Schmidt PJ. Transfusion mortality; with special reference to surgical and intensive care facilities. J Fla Med Assoc 1980; 67: 151–3
- Tullis JL. The impact of advances in blood transfusion. In: Hubbell RC, ed. Advances in blood transfusion. Arlington, Va: American Blood Commission, 1979: 40
- Mollison PL. Blood transfusion in clinical medicine. 6th ed. Oxford, England? Blackwell Scientific Publications, 1979
- Aach RD, Kahn RA. Post-transfusion hepatitis: current perspectives. Ann Intern Med 1980; 92: 539–46
- Seeff LB, Wright EC, Zimmerman HG, et al. VA cooperative study of post-transfusion hepatitis, 1969–1974: incidence and characteristics of hepatitis and responsible risk factors. Am J Med Sci 1975; 270: 355–62
- Ahrons S, Kissmeyer-Nielsen F. Serological investigations of 1,358 transfusion reactions in 74,000 transfusions. Dan Med Bull 1968; 15: 259–62
- Pineda AA, Brzica SM Jr, Taswell HF. Hemolytic transfusion reaction: recent experience in a large blood bank. Mayo Clin Proc 1978; 53: 378–90
- Solanki D, McCurdy PR. Delayed hemolytic transfusion reactions? an often-missed entity. JAMA 1978: 239: 729–31
- Bailey MJ, Johnston CL, Yates CJ, et al. Pre-operative haemoglobin as predictor of outcome of diabetic amputations. Lancet 1979; 2: 1968–70
- Thomas DJ, Marshall J, Russell RW, et al. Effect of haematocrit on cerebral blood-flow in man. Lancet 1977; 2: 941–3
- Yates CJ, Berent A, Andrews V, et al. Increase in leg blood-flow by normovolaemic haemodilution in intermittent claudication. Lancet 1979; 2: 166–8
- McCullough J, Burke ME, Wood N, et al. Microcapillary agglutination for the detection of leukocyte antibodies? evaluation of the method and clinical significance in transfusion reactions. Transfusion 1974; 14: 425–32
- Hasegawa T, Bergh OJ, Terasaki PI, et al. Occurrence of granulocyte cytotoxins and agglutinins. Transfusion 1975; 15: 226–30
- Ungerleider RS, Appelbaum FR, Trapani RJ, et al. Lack of predictive value of antileukocyte antibody screening in granulocyte transfusion therapy. Transfusion 1979: 19: 90–4
- Polesky HF. Leucocyte-poor blood, a study in the evolution of component therapy. In: Seminar on blood components: e unum pluribus. American Association of Blood Banks, Washington DC, 1977
- Koistinen J, Leikola J. Weak anti-IgA antibodies with limited specificity and nonhemolytic transfusion reactions. Vox Sang 1977; 32: 77–81
- Rivat L, Rivat C, Daveau M, et al. Comparative frequencies of anti-IgA antibodies among patients with ana- phylactic transfusion reactions and among normal blood donors. Clin Immunol Immunopathol 1977; 7: 340–8
- Milner LV, Butcher K. Transfusion reactions reported after transfusions of red blood cells and of whole blood. Transfusion 1978; 18: 493–5
- Wells JV, Buckley RH, Schanfield MS, et al. Anaphylactic reactions to plasma infusions in patients with hypogammaglobulinemia and anti-IgA antibodies. Clin Immunol Immunopathol 1977; 8: 265–71